Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models.
about
Normal tissue complication probability modeling for cochlea constraints to avoid causing tinnitus after head-and-neck intensity-modulated radiation therapy.A data-mining framework for large scale analysis of dose-outcome relationships in a database of irradiated head and neck cancer patients.Normal tissue studies in radiation oncology: A systematic review of highly cited articles and citation patterns.The different dose-volume effects of normal tissue complication probability using LASSO for acute small-bowel toxicity during radiotherapy in gynecological patients with or without prior abdominal surgery.A fast optimization algorithm for multicriteria intensity modulated proton therapy planning.Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from radiation therapy oncology group protocol 94-06.Therapy Operating Characteristic (TOC) Curves and their Application to the Evaluation of Segmentation Algorithms.Late rectal toxicity on RTOG 94-06: analysis using a mixture Lyman modelComparison of prostate IMRT and VMAT biologically optimised treatment plans.Prediction of gastrointestinal toxicity after external beam radiotherapy for localized prostate cancer.Normal tissue complication models for clinically relevant acute esophagitis (≥ grade 2) in patients treated with dose differentiated accelerated radiotherapy (DART-bid).Radiation dose-volume effects in radiation-induced rectal injury.Personalized treatment planning with a model of radiation therapy outcomes for use in multiobjective optimization of IMRT plans for prostate cancerClinical implications in the use of the PBC algorithm versus the AAA by comparison of different NTCP models/parameters.A decision aid for intensity-modulated radiation-therapy plan selection in prostate cancer based on a prognostic Bayesian network and a Markov model.Equivalence of Gyn GEC-ESTRO guidelines for image guided cervical brachytherapy with EUD-based dose prescription.Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlasPredictive models of toxicity in external radiotherapy: dosimetric issues.Predictive models of toxicity with external radiotherapy for prostate cancer: clinical issues.Reducing rectal injury during external beam radiotherapy for prostate cancer.The evolution of rectal and urinary toxicity and immune response in prostate cancer patients treated with two three-dimensional conformal radiotherapy techniques.Voxel-based population analysis for correlating local dose and rectal toxicity in prostate cancer radiotherapy.Accumulated dose to the rectum, measured using dose-volume histograms and dose-surface maps, is different from planned dose in all patients treated with radiotherapy for prostate cancerReducing rectal injury in men receiving prostate cancer radiation therapy: current perspectives.Clinical and dosimetric predictors of late rectal bleeding of prostate cancer after TomoTherapy intensity modulated radiation therapy.A comparison of HDR brachytherapy and IMRT techniques for dose escalation in prostate cancer: a radiobiological modeling study.A comparison of dose-response characteristics of four NTCP models using outcomes of radiation-induced optic neuropathy and retinopathy.Radiobiological comparison of two radiotherapy treatment techniques for high-risk prostate cancer.Two-dimensional imaging of tumour control probabilities and normal tissue complication probabilities.Feasibility of safe ultra-high (EQD(2)>100 Gy) dose escalation on dominant intra-prostatic lesions (DILs) by Helical Tomotheraphy.Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer.Radiation treatment parameters for re-irradiation of malignant glioma.Dosimetric and radiobiological comparison of Cyberknife and Tomotherapy in stereotactic body radiotherapy for localized prostate cancer.Normal tissue complication probability modeling of radiation-induced sensorineural hearing loss after head-and-neck radiation therapy.Dosimetric assessment of prostate cancer patients through principal component analysis (PCA).Plan robustness of simultaneous integrated boost radiotherapy of prostate and lymph nodes for different image-guidance and delivery techniques.Using Bayesian logistic regression to evaluate a new type of dosimetric constraint for prostate radiotherapy treatment planning.Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?Dosimetric and anatomic indicators of late rectal toxicity after high-dose intensity modulated radiation therapy for prostate cancer.
P2860
Q30402671-0FB56343-9E9F-4A8B-B6DB-28E2FBC41D3DQ30978160-A9845A41-52EC-4A84-B970-A5688C4F869EQ33967649-BA9BFBFE-C617-49F2-B0D3-EEFFCDF78BC7Q34014421-3EDCA52A-CBD5-46CB-BF2D-9B8915CD192BQ34137686-DC3BA091-C889-48D3-8720-918FC8334AC2Q34161145-816D0C90-9DAC-46F6-96AE-8C85A1A10AA7Q34189732-DC51FE0D-59AE-45BF-AEEB-3D83211ED264Q34238364-FB988980-D67A-4307-8D22-589A4CC096EFQ34372750-D6527E43-70DC-47D8-8DB3-3B5B511660C0Q35500065-4327C6AB-4A58-4FBB-9A34-A14C390F1CBDQ35669846-F5A31DBC-69F4-4C45-A3B5-3B875252F635Q35870610-95594549-EC05-4595-A08F-82002EBA5119Q36679026-36AED50A-6FC1-473E-89B1-94DBA543897EQ37113684-A8E612D9-0420-4E9C-9B78-DB807B5311CBQ37198226-70500C21-73BB-4383-829D-05BA8C08156EQ37348135-2992D5F5-374D-4BB2-A69E-FAB21BB6CFC2Q37523270-1990B2AE-24C7-4399-BD31-BF49F38CFDFAQ37526771-7ED15130-334F-4C02-913F-1B21000C95C6Q37526775-40139CDA-BEB1-4AFC-85D8-E79DC93FD462Q38106626-7E82C717-A6A1-4C46-8584-A25A0DD4D46BQ38266168-84A331BD-A172-44D3-8034-9DD46109D8F6Q38721165-2271CD0E-E4BC-4EE4-888B-741CA65E4868Q38981805-405C0C2D-1B19-496B-A0B8-485645BC67ABQ41276603-AC9A1B10-8460-45D2-BF73-DA9ED005FB9AQ41633588-EAEECC24-CA54-4C87-8260-0963AB2E23FEQ41887636-62937CDA-06DB-4C05-8BE2-49D34AB9141AQ41958505-C169EF2F-9651-4F0E-BED3-211A0CBF7EE9Q42128313-3CA48FDB-0AF3-43E3-98E7-FD18BC3DFFCEQ42707663-83B5AD9B-58C6-4249-94C4-51EEB5C1E8AAQ45070750-D38EAFE3-96AD-4EFB-BCB2-6549C9A75536Q45213721-FCF36EEE-4FB6-4249-8FA0-14462D8E8F46Q46154560-442F411B-2679-42FB-BACB-4DD7DBA51A69Q46838608-A161E654-1B58-470C-9CE3-E782E2FD6477Q47887578-5CC15576-6526-4AD5-88CA-3A56A8D2C2EAQ50485231-87ACB864-7432-4E83-85B3-AB56BE13C4FCQ51547371-1F4A3972-648B-48A0-94C3-3404FC668E45Q51699959-D738D9FD-C7F9-4CC0-8554-D6BC94279094Q52958760-EB7B3059-2605-418D-8F71-CE927CCBA17CQ54034691-4C32AA4F-E8B1-4945-89C5-61C0936F6347
P2860
Incidence of late rectal bleeding in high-dose conformal radiotherapy of prostate cancer using equivalent uniform dose-based and dose-volume-based normal tissue complication probability models.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Incidence of late rectal bleed ...... mplication probability models.
@en
type
label
Incidence of late rectal bleed ...... mplication probability models.
@en
prefLabel
Incidence of late rectal bleed ...... mplication probability models.
@en
P2093
P2860
P1476
Incidence of late rectal bleed ...... mplication probability models.
@en
P2093
Carlos Vargas
Elisa Meldolesi
Jian Liang
Markus Alber
Matthias Söhn
P2860
P304
P356
10.1016/J.IJROBP.2006.10.014
P407
P577
2007-01-26T00:00:00Z